Antoine Adenis

Trials

Studies that name Antoine Adenis as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:52 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT06539130 · Medical Practices and Representations of People From Haiti in French Guiana

  Centre Hospitalier de Cayenne · completed · Social Representations of Infectious Diseases · study director
• Ph1/Ph2
  NCT03828799 · Safety, Tolerability and Efficacy of Regorafenib in Combination With FOLFIRINOX in Patients With Colorectal Cancer

  Institut du Cancer de Montpellier - Val d'Aurelle · completed · Metastatic Colorectal Cancer · study chair
• Ph3
  NCT02853474 · Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy

  Centre Oscar Lambret · completed · Gastric Cancer, Pancreas Cancer, Bile Duct Cancer · principal investigator
• Ph2
  NCT02359968 · PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer

  Centre Oscar Lambret · completed · Esophageal Neoplasms, Gastro-esophageal Junction Cancer · principal investigator
• N/A
  NCT02310477 · Regorafenib in Metastatic Colorectal Cancer : a Cohort Study in the Real-life Setting

  Centre Oscar Lambret · completed · Metastatic Colorectal Cancer · principal investigator
• Ph2
  NCT02173990 · Aflibercept and Chemotherapy as First Line Treatment for Metastatic Colorectal Cancer Assessable With DCE-US (PULSAR).

  Centre Oscar Lambret · terminated · Metastatic Colorectal Cancer · study director
• Ph2
  NCT01919879 · Dual Targeting of EGFR With Cetuximab and Afatinib to Treat Refractory wtKRAS Metastatic Colorectal Cancer

  UNICANCER · completed · Metastatic Colorectal Cancer · principal investigator
• N/A
  NCT01525953 · Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis

  Centre Oscar Lambret · completed · Esophageal Cancer · principal investigator
• Ph2
  NCT01443065 · MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma

  UNICANCER · completed · Malignant Neoplasm of Esophagus, Malignant Neoplasm of Stomach · principal investigator
• Ph2
  NCT01442649 · Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab

  UNICANCER · completed · Colorectal Cancer · principal investigator
• Ph2
  NCT01248299 · Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer.

  Centre Oscar Lambret · terminated · Squamous Cell Carcinoma of Esophagus · principal investigator
• N/A
  NCT01248429 · Prevalence of Creatinine Phosphokinase Increase in Patients With Solid Tumors Treated by Inhibitors of Tyrosine Kinases

  Centre Oscar Lambret · completed · Cancer, Solid Tumor · principal investigator
• Ph1
  NCT01046487 · Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate

  Centre Oscar Lambret · completed · Cancer · principal investigator
• Ph3
  NCT00812240 · Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)

  AB Science · terminated · Gastrointestinal Stromal Tumors · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 01:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.